---
created: 2025-04-13
updated: 2025-04-13T10:52
id: Eu7A*Qk[9;
specialty: immuno
specialty_id: 106
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::natalizumab
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::immunology-&-biochemistry-pharmacology::immuno-suppressives::general-immunotherapy
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Natalizumab is a monoclonal antibody against **α4-integrin** used to treat **Multiple Sclerosis** and **Crohn disease**

---

# Answer
α4-integrin is responsible for WBC adhesion